메뉴 건너뛰기




Volumn 13, Issue 10, 2002, Pages 1650-1655

Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience)

Author keywords

Doxorubicin bleomycin vinblastine darcarbazine; Hodgkin's disease; Mustine vincristine procarbazine prednisone; Refractory; Relapsed

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; LOMUSTINE; PREDNIMUSTINE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

EID: 0036810243     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf271     Document Type: Article
Times cited : (16)

References (40)
  • 1
    • 0014893444 scopus 로고
    • Combination chemotherapy in the treatment of advanced Hodgkin's disease
    • DeVita VT Jr, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970; 73: 881-895.
    • (1970) Ann. Intern. Med , vol.73 , pp. 881-895
    • DeVita V.T., Jr.1    Serpick, A.A.2    Carbone, P.P.3
  • 2
    • 0016707139 scopus 로고
    • Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP
    • Bonadona G, Zucali R, Monfardini S et al. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 1975; 36: 252-259.
    • (1975) Cancer , vol.36 , pp. 252-259
    • Bonadona, G.1    Zucali, R.2    Monfardini, S.3
  • 3
    • 0022553175 scopus 로고
    • Twenty years of MOPP therapy for Hodgkin's disease
    • Longo DL, Young RC, Wesley M et al. Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol 1986; 4: 1295-1306.
    • (1986) J. Clin. Oncol , vol.4 , pp. 1295-1306
    • Longo, D.L.1    Young, R.C.2    Wesley, M.3
  • 4
    • 0011440695 scopus 로고
    • Chemotherapy for Hodgkin's disease. Section II: Alternative combinations and new approaches
    • Selby P, McElwain TJ (eds): Oxford: Blackwell Scientific Publications
    • Canellos GP, Selby P, McElwain TJ. Chemotherapy for Hodgkin's disease. Section II: alternative combinations and new approaches. In Selby P, McElwain TJ (eds): Hodgkin's Disease. Oxford: Blackwell Scientific Publications 1987; 285-300.
    • (1987) Hodgkin's Disease , pp. 285-300
    • Canellos, G.P.1    Selby, P.2    McElwain, T.J.3
  • 5
    • 0026439199 scopus 로고
    • Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD
    • Canellos GP, Anderson JR, Propert KJ et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992; 327: 1478-1484.
    • (1992) N. Engl. J. Med , vol.327 , pp. 1478-1484
    • Canellos, G.P.1    Anderson, J.R.2    Propert, K.J.3
  • 6
    • 0031033626 scopus 로고    scopus 로고
    • Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD
    • Bonfante V, Santoro A, Viviani S et al. Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. J Clin Oncol 1997; 15: 528-534.
    • (1997) J. Clin. Oncol , vol.15 , pp. 528-534
    • Bonfante, V.1    Santoro, A.2    Viviani, S.3
  • 7
    • 0011449354 scopus 로고    scopus 로고
    • Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: The low probability for cure
    • Longo DL, Duffey PL, Young RC et al. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. J Clin Oncol 1997; 15: 528-534.
    • (1997) J. Clin. Oncol , vol.15 , pp. 528-534
    • Longo, D.L.1    Duffey, P.L.2    Young, R.C.3
  • 8
    • 0026329564 scopus 로고
    • Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease
    • Armitage JO, Bierman PJ, Vose JM et al. Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease. Am J Med 1991; 91: 605-611.
    • (1991) Am. J. Med , vol.91 , pp. 605-611
    • Armitage, J.O.1    Bierman, P.J.2    Vose, J.M.3
  • 9
    • 0027742164 scopus 로고
    • High dose sequential chemoradiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease. A 6-year update
    • Gianni AM, Siena S, Bregni M et al. High dose sequential chemoradiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease. A 6-year update. Ann Oncol 1993; 4: 889-891.
    • (1993) Ann. Oncol , vol.4 , pp. 889-891
    • Gianni, A.M.1    Siena, S.2    Bregni, M.3
  • 10
    • 0027404777 scopus 로고
    • Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial
    • Linch DC, Winfield D, Goldstone AH et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 1993; 341: 1051-1054.
    • (1993) Lancet , vol.341 , pp. 1051-1054
    • Linch, D.C.1    Winfield, D.2    Goldstone, A.H.3
  • 11
    • 0014258292 scopus 로고
    • International conference on leukaemia-lymphoma
    • Benzel JE. International conference on leukaemia-lymphoma, Ann Arbor, Michigan. Del Med J 1967; 40: 78-81.
    • (1967) Ann Arbor. Michigan Del. Med. J , vol.40 , pp. 78-81
    • Benzel, J.E.1
  • 12
    • 0021130371 scopus 로고
    • Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP, ABVD and B-CAVe
    • Harker WG, Kushlan P, Rosenberg SA. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP, ABVD and B-CAVe. Ann Intern Med 1984; 101: 440-446.
    • (1984) Ann. Intern. Med , vol.101 , pp. 440-446
    • Harker, W.G.1    Kushlan, P.2    Rosenberg, S.A.3
  • 13
    • 0029113713 scopus 로고
    • Etoposide, vinblastine, and doxorubicin: An active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B
    • Canellos GP, Petroni GR, Barcos M et al. Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B. J Clin Oncol 1995; 13: 2005-2011.
    • (1995) J. Clin. Oncol , vol.13 , pp. 2005-2011
    • Canellos, G.P.1    Petroni, G.R.2    Barcos, M.3
  • 15
    • 0023835089 scopus 로고
    • Risk of second cancers after treatment for Hodgkin's disease
    • Tucker MA, Coleman CN, Cox RS et al. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988; 318: 76-81.
    • (1988) N. Engl. J. Med , vol.318 , pp. 76-81
    • Tucker, M.A.1    Coleman, C.N.2    Cox, R.S.3
  • 16
    • 0024352213 scopus 로고
    • Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease
    • van Leeuwen FE, Somers R, Taal BG et al. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol 1989; 7: 1046-1058.
    • (1989) J. Clin. Oncol , vol.7 , pp. 1046-1058
    • van Leeuwen, F.E.1    Somers, R.2    Taal, B.G.3
  • 17
    • 0000352307 scopus 로고
    • Leukemias, non-Hodgkin's lymphomas and solid tumors in patients treated for Hodgkin's disease
    • Coleman C, Kaplan HS, Cox R et al. Leukemias, non-Hodgkin's lymphomas and solid tumors in patients treated for Hodgkin's disease. Cancer Surv 1982; 1: 733-743.
    • (1982) Cancer Surv , vol.1 , pp. 733-743
    • Coleman, C.1    Kaplan, H.S.2    Cox, R.3
  • 18
    • 0021062139 scopus 로고
    • Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease
    • Henry-Amar M. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease. J Natl Cancer Inst 1983; 71: 911-916.
    • (1983) J. Natl. Cancer Inst , vol.71 , pp. 911-916
    • Henry-Amar, M.1
  • 19
    • 0021964253 scopus 로고
    • Lung cancer in Hodgkin's disease: Association with previous radiotherapy
    • List AF, Doll DC, Greco FA. Lung cancer in Hodgkin's disease: association with previous radiotherapy. J Clin Oncol 1985; 3: 215-221.
    • (1985) J. Clin. Oncol , vol.3 , pp. 215-221
    • List, A.F.1    Doll, D.C.2    Greco, F.A.3
  • 20
    • 0033816125 scopus 로고    scopus 로고
    • MiCMA: An alternative treatment for refractory or recurrent Hodgkin's disease
    • La Barbera EO, Chiusolo P, Laurenti L et al. MiCMA: an alternative treatment for refractory or recurrent Hodgkin's disease. Ann Oncol 2000; 11: 867-871.
    • (2000) Ann. Oncol , vol.11 , pp. 867-871
    • La Barbera, E.O.1    Chiusolo, P.2    Laurenti, L.3
  • 21
    • 0033846566 scopus 로고    scopus 로고
    • CN3OP: An active regimen in patients with relapsed/refractory Hodgkin's lymphoma
    • Walewski J, Krzyzanowska JB, Kraszewska E et al. CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma. Med Oncol 2000; 17: 195-202.
    • (2000) Med. Oncol , vol.17 , pp. 195-202
    • Walewski, J.1    Krzyzanowska, J.B.2    Kraszewska, E.3
  • 22
    • 0032947935 scopus 로고    scopus 로고
    • ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: A study in 36 patients
    • Saletti P, Zucca E, Gueneau M et al. ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: a study in 36 patients. Leuk Lymphoma 1999; 33: 313-319.
    • (1999) Leuk. Lymphoma , vol.33 , pp. 313-319
    • Saletti, P.1    Zucca, E.2    Gueneau, M.3
  • 23
    • 0033437129 scopus 로고    scopus 로고
    • High-dose chemotherapy with G-CSF in refractory Hodgkin's disease
    • Aviles A, Garcia EL, Cuadra I, Diaz-Maqueo JC. High-dose chemotherapy with G-CSF in refractory Hodgkin's disease. Leuk Lymphoma 1999; 36: 139-145.
    • (1999) Leuk. Lymphoma , vol.36 , pp. 139-145
    • Aviles, A.1    Garcia, E.L.2    Cuadra, I.3    Diaz-Maqueo, J.C.4
  • 24
    • 0023267126 scopus 로고
    • MIME chemotherapy as treatment for recurrent Hodgkin's disease
    • Hagemeister FB, Tannir N, McLaughlin P et al. MIME chemotherapy as treatment for recurrent Hodgkin's disease. J Clin Oncol 1987; 5: 556-561.
    • (1987) J. Clin. Oncol , vol.5 , pp. 556-561
    • Hagemeister, F.B.1    Tannir, N.2    McLaughlin, P.3
  • 25
    • 0025337574 scopus 로고
    • Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphoma. The Swedish Lymphoma Study Group
    • Enblad G, Glimelius B, Hagberg H, Lindemalm C. Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphoma. The Swedish Lymphoma Study Group. Acta Oncol 1990; 29: 297-301.
    • (1990) Acta Oncol , vol.29 , pp. 297-301
    • Enblad, G.1    Glimelius, B.2    Hagberg, H.3    Lindemalm, C.4
  • 26
    • 0031918129 scopus 로고    scopus 로고
    • Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: A prospective study
    • Enblad G, Hagberg H, Gustavsson A, Glimelius B. Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: a prospective study. Eur J Haematol 1998; 60: 166-171.
    • (1998) Eur. J. Haematol , vol.60 , pp. 166-171
    • Enblad, G.1    Hagberg, H.2    Gustavsson, A.3    Glimelius, B.4
  • 27
    • 0032976642 scopus 로고    scopus 로고
    • ESHAP is an active regimen for relapsing Hodgkin's disease
    • Aparicio J, Segura A, Garcera. S et al. ESHAP is an active regimen for relapsing Hodgkin's disease. Ann Oncol 1999; 10: 593-595.
    • (1999) Ann. Oncol , vol.10 , pp. 593-595
    • Aparicio, J.1    Segura, A.2    Garcera, S.3
  • 28
    • 0023484082 scopus 로고
    • Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to COPP and ABVD: A multicenter trial of German Hodgkin Study Group
    • Pfreundschuh MG, Schoppe WD, Fuchs R et al. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to COPP and ABVD: a multicenter trial of German Hodgkin Study Group. Cancer Treat Rep 1987; 71: 1203-1207.
    • (1987) Cancer Treat. Rep , vol.71 , pp. 1203-1207
    • Pfreundschuh, M.G.1    Schoppe, W.D.2    Fuchs, R.3
  • 29
    • 0029099436 scopus 로고
    • The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease
    • Ferme C, Bastion Y, Lepage E et al. The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease. Ann Oncol 1995; 6: 543-549.
    • (1995) Ann. Oncol , vol.6 , pp. 543-549
    • Ferme, C.1    Bastion, Y.2    Lepage, E.3
  • 31
    • 0027722082 scopus 로고
    • CAPE/PALE salvage chemotherapy for Hodgkin's disease patients relapsing within 1 year of ChlVPP chemotherapy
    • Fairey AF, Mead GM, Jones HE et al. CAPE/PALE salvage chemotherapy for Hodgkin's disease patients relapsing within 1 year of ChlVPP chemotherapy. Ann Oncol 1993; 4: 857-860.
    • (1993) Ann. Oncol , vol.4 , pp. 857-860
    • Fairey, A.F.1    Mead, G.M.2    Jones, H.E.3
  • 32
    • 0028245954 scopus 로고
    • Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease
    • Brusamolino E, Orlandi E, Canevari A et al. Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease. Ann Oncol 1994; 5: 427-432.
    • (1994) Ann. Oncol , vol.5 , pp. 427-432
    • Brusamolino, E.1    Orlandi, E.2    Canevari, A.3
  • 33
    • 0033153007 scopus 로고    scopus 로고
    • ASHAP: A regimen for cytoreduction of refractory or recurrent Hodgkin's disease
    • Rodriguez J, Rodriguez MA, Fayad L et al. ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's disease. Blood 1999; 93: 3632-3636.
    • (1999) Blood , vol.93 , pp. 3632-3636
    • Rodriguez, J.1    Rodriguez, M.A.2    Fayad, L.3
  • 34
    • 0031892206 scopus 로고    scopus 로고
    • Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplant
    • Little R, Wittes RE, Longo DL, Wilson WH. Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplant. J Clin Oncol 1998; 16: 584-588.
    • (1998) J. Clin. Oncol , vol.16 , pp. 584-588
    • Little, R.1    Wittes, R.E.2    Longo, D.L.3    Wilson, W.H.4
  • 35
    • 0011449357 scopus 로고    scopus 로고
    • Phase II study of gemcitabine in patients with multiple pretreated Hodgkin's disease-results of multicenter study
    • Tesch H, Santoro A, Fiedler F et al. Phase II study of gemcitabine in patients with multiple pretreated Hodgkin's disease-results of multicenter study. Leuk Lymphoma 1998; 29 (Suppl 1): 103.
    • (1998) Leuk. Lymphoma , vol.29 , Issue.SUPPL. 1 , pp. 103
    • Tesch, H.1    Santoro, A.2    Fiedler, F.3
  • 36
    • 0033932803 scopus 로고    scopus 로고
    • Gemcitabine in treatment of refractory Hodgkin's disease: Results of a multicenter phase II study
    • Santoro A, Bredenfeld H, Devizzi L et al. Gemcitabine in treatment of refractory Hodgkin's disease: results of a multicenter phase II study. J Clin Oncol 2000; 18: 2615-2619.
    • (2000) J. Clin. Oncol , vol.18 , pp. 2615-2619
    • Santoro, A.1    Bredenfeld, H.2    Devizzi, L.3
  • 37
    • 0032761285 scopus 로고    scopus 로고
    • Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma
    • Moskowitz CH, Bertino JR, Glassman JR et al. Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. J Clin Oncol 1999; 17: 3776-3785
    • (1999) J. Clin. Oncol , vol.17 , pp. 3776-3785
    • Moskowitz, C.H.1    Bertino, J.R.2    Glassman, J.R.3
  • 38
    • 0028819356 scopus 로고
    • Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation
    • Colwill R, Crump M, Couture F et al. Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation. J Clin Oncol 1995; 13: 396-402.
    • (1995) J. Clin. Oncol , vol.13 , pp. 396-402
    • Colwill, R.1    Crump, M.2    Couture, F.3
  • 39
    • 0032448066 scopus 로고    scopus 로고
    • The case for and against high-dose chemotherapy with stem cell rescue for early poor prognosis Hodgkin's disease in first remission
    • Goldstone A. The case for and against high-dose chemotherapy with stem cell rescue for early poor prognosis Hodgkin's disease in first remission. Ann Oncol 1998; 9 (Suppl): 83-85.
    • (1998) Ann. Oncol , vol.9 , Issue.SUPPL. , pp. 83-85
    • Goldstone, A.1
  • 40
    • 0033783428 scopus 로고    scopus 로고
    • High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: Long-term outcome and prognostic factors
    • Neben K, Hohaus S, Goldschmidt H et al. High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors. Ann Hematol 2000; 79: 547-555.
    • (2000) Ann. Hematol , vol.79 , pp. 547-555
    • Neben, K.1    Hohaus, S.2    Goldschmidt, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.